Insulin-like growth factor-1/insulin bypasses Pref-1/FA1-mediated inhibition of adipocyte differentiation

J Biol Chem. 2003 Jun 6;278(23):20906-14. doi: 10.1074/jbc.M300022200. Epub 2003 Mar 21.

Abstract

Pref-1 is a highly glycosylated Delta-like transmembrane protein containing six epidermal growth factor-like repeats in the extracellular domain. Pref-1 is abundantly expressed in preadipocytes, but expression is down-regulated during adipocyte differentiation. Forced expression of Pref-1 in 3T3-L1 cells was reported to inhibit adipocyte differentiation. Here we show that efficient and regulated processing of Pref-1 occurs in 3T3-L1 preadipocytes releasing most of the extracellular domain as a 50-kDa heterogeneous protein, previously isolated and characterized as FA1. Unexpectedly, we found that forced expression of the soluble form, FA1, or full-length Pref-1 did not inhibit adipocyte differentiation of 3T3-L1 cells when differentiation was induced by standard treatment with methylisobutylxanthine, dexamethasone, and high concentrations of insulin. However, forced expression of either form of Pref-1/FA1 in 3T3-L1 or 3T3-F442A cells inhibited adipocyte differentiation when insulin or insulin-like growth factor-1 (IGF-1) was omitted from the differentiation mixture. We demonstrate that the level of the mature form of the IGF-1 receptor is reduced and that IGF-1-dependent activation of p42/p44 mitogen-activated protein kinases (MAPKs) is compromised in preadipocytes with forced expression of Pref-1. This is accompanied by suppression of clonal expansion and terminal differentiation. Accordingly, supplementation with insulin or IGF-1 rescued p42/p44 MAPK activation, clonal expansion, and adipocyte differentiation in a dose-dependent manner.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-3-isobutylxanthine / pharmacology
  • 3T3 Cells
  • Adipocytes / cytology*
  • Adipocytes / metabolism
  • Animals
  • Calcium-Binding Proteins
  • Cell Differentiation / physiology
  • Dexamethasone / pharmacology
  • Gene Expression Regulation
  • Glucocorticoids / pharmacology
  • Hypoglycemic Agents / pharmacology*
  • Insulin / pharmacology*
  • Insulin-Like Growth Factor I / pharmacology*
  • Intercellular Signaling Peptides and Proteins
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / physiology
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism*
  • Mice
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases / metabolism
  • Phosphodiesterase Inhibitors / pharmacology
  • Repressor Proteins / genetics
  • Repressor Proteins / metabolism*

Substances

  • Calcium-Binding Proteins
  • Dlk1 protein, mouse
  • Glucocorticoids
  • Hypoglycemic Agents
  • Insulin
  • Intercellular Signaling Peptides and Proteins
  • Membrane Proteins
  • Phosphodiesterase Inhibitors
  • Repressor Proteins
  • Insulin-Like Growth Factor I
  • Dexamethasone
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases
  • 1-Methyl-3-isobutylxanthine